A UK based SME, has commercialised a single use, disposable face shield visor and cape to improve biological barrier protection for healthcare staff from COVID-‐19. They seek licensing and manufacturing agreements with organisations that have knowledge of similar products. This product has been designed following engagement with front-‐line healthcare staff. It is lightweight, easy to put on and off and comfortable to wear. Prototypes are available for demonstration.
Sneezing, coughing and speaking has been shown to release infected COVID-‐19 respiratory droplets. Direct infection transmission can occur when these droplets travel from the respiratory tract of an infectious individual to susceptible mucosal surfaces of a recipient. Droplets can also settle on surfaces, later to be touched and carried on hands leading to self-‐inoculation (in-‐direct transmission). Current personal protective equipment (PPE) options available to healthcare staff have been associated with a number of identified problems. For example, eye protection goggles are generally not disposable, they fog after extended use, tempt healthcare workers to manipulate them with contaminated gloved hands and do not cover the skin completely. On the other hand, many visors currently used are of variable quality, comfort & design. In particular these also fail to cover the skin completely and flaring of the visor edges, distal to the headband support, increases skin exposure to infected respiratory droplets further. When healthcare staff stand over supine patients to perform aerosol generating procedures the direction of droplet dispersal is of particular concern. Significant risk exists to healthcare personnel when personal protective equipment fails to optimally cover their skin from infected droplet deposits which can later be touched and carried on hands leading to self-‐inoculation. Our face shield visor and cape (UK Patent application in process) mitigates the above risks described and optimally improves biological barrier protection. They are seeking manufacturers via a manufacturing agreement and also licensing agreements.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
Infection prevention control teams (based within Ambulance Services (pre-‐hospital), Hospitals and Primary Care Consortiums) to conduct collaborative feasibility trials of their prototype models. 2.Dialogue, with distributors that have experience with healthcare systems, to discuss a future distribution services agreement. The partner company would ideally have experience of medical device distribution, particularly personal protective equipment, and have active links to exploit. Due to the current COVID-‐19 crisis, following successful feasibility trials, their ambition is to rapidly take this product to market.They have already secured partnership with a materials supplier and have production lines with capacity to deliver on a large scale. It is envisaged that the partnership will take the form of a manufacturing agreement but also could be under a licence agreement depending on the circumstances and the type of partner.
Stage of Development:
Prototype available for demonstration
Patent(s) applied for but not yet granted